PELOBIOTECH GmbH is happy to announce organizing the first conference "Advancements in Animal-Free Research and Translational Medicine" in Munich/Gräfelfing. Scheduled for June 27, 2024, this conference aims to spotlight novel non-animal approaches vital for progress in translational medical research. The Munich Cell Specialist PELOBIOTECH distributes one of the broadest portfolios of 2D&3D cell culture systems, cell culture products and media.
The conference will start with an overview of the development and validation of serum substitutes. “Paving the way for ethically sound alternatives is crucial today for scientific advancements”, said Dr. Lothar Steeb, Co-CEO&CSO PELOBiotech. In addition to getting insights on the principles of cell culture and stem cells, presentations will focus on applications and hands-on experiences in the lab. “We are happy to have gained so many experts from the scientific community to offer a great networking opportunity beyond their research fields”, said Dr. Peter Frost, CEO PELOBIOTECH GmbH.
The focus is on networking and collaboration between scientists and experts in the field. An organized face-to-face lunch and breaks with the speakers will provide ample time for an exchange of views and further questions. A panel discussion with concluding remarks and a toast at the rooftop bar will provide an opportunity to ask for final follow-ups.
Attendees can expect an overview of numerous innovative applications throughout the day. Highlighted topics include serum-free media and serum alternatives, the translational applicability of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in therapeutic contexts, the utilization of human adipocyte spheroids for obesity research, and the scalability of cardiac organoids for preclinical applications in cardiovascular research and pharmacology.
PELOBIOTECH’s CEOs, Dr. Peter Frost and Dr. Lothar Steeb, will kick off the conference, followed by presentations from speakers such as
Conference Details:
The conference will start with an overview of the development and validation of serum substitutes. “Paving the way for ethically sound alternatives is crucial today for scientific advancements”, said Dr. Lothar Steeb, Co-CEO&CSO PELOBiotech. In addition to getting insights on the principles of cell culture and stem cells, presentations will focus on applications and hands-on experiences in the lab. “We are happy to have gained so many experts from the scientific community to offer a great networking opportunity beyond their research fields”, said Dr. Peter Frost, CEO PELOBIOTECH GmbH.
The focus is on networking and collaboration between scientists and experts in the field. An organized face-to-face lunch and breaks with the speakers will provide ample time for an exchange of views and further questions. A panel discussion with concluding remarks and a toast at the rooftop bar will provide an opportunity to ask for final follow-ups.
Attendees can expect an overview of numerous innovative applications throughout the day. Highlighted topics include serum-free media and serum alternatives, the translational applicability of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in therapeutic contexts, the utilization of human adipocyte spheroids for obesity research, and the scalability of cardiac organoids for preclinical applications in cardiovascular research and pharmacology.
PELOBIOTECH’s CEOs, Dr. Peter Frost and Dr. Lothar Steeb, will kick off the conference, followed by presentations from speakers such as
- Prof. Dr. Gerhard Gstraunthaler, Institut für Physiologie der Medizinischen Universität Innsbruck, emer
- Prof. Dr. rer. nat. Bernd Giebel, Institut für Transfusionsmedizin, Universitätsklinikum Essen
- PD Dr. Kurt Pfannkuche, Faculty of Medicine, Universität zu Köln
- Dr. rer. nat. Anita Wagner, Lehrstuhl für Molekulare Ernährungsmedizin, Technische Universität München (TUM)
- Dr. Flavia Rezende, Center for Molecular Medicine, Goethe-Universität Frankfurt
- Dr. Raquel Sousa, abc biopply, Cham, Switzerland
Conference Details:
- Date: June 27, 2024
9 AM to 5 PM - Location: GREFIS Hotel GmbH, Lohenstraße 5, 82166 Gräfelfing, Germany
- Registration: Early Bird and PELOClub Members: 349 Euros (register by April 30, 2024) | Standard fee: 399 Euros
- Upon request, certificates of registration and attendance will be provided.
- Registration: Email conference@pelobiotech.com; https://www.pelobiotech.com/resources/conferences.html
